Back to VANGUARD GROUP INC VANGUARD GROUP INC

TNXPTNXP
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in TONIX PHARMACEUTICALS HLDG C

VANGUARD GROUP INC holds 673,605 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $10.5M as of 2025-Q4. The position was increased (+20.9% shares). TNXP represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$10.5M

Current Shares

673,605

Total Value Change

+$8.9M

Total Shares Change

+582,109

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
673,605
+20.9%
$10.5M0.0%$15.82
33
2025-Q3
Increased
556,957
+238.1%
$13.5M0.0%$24.76
45
2025-Q2
Increased
164,732
+80.0%
$5.9M0.0%$34.89
42
2025-Q1
New
91,496
-
$1.6M0.0%$20.17
39

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used